Achieve Life Sciences, Inc. Cash and Restricted Cash
Achieve Life Sciences, Inc. (ACHV) had Cash and Restricted Cash of $4.44 million as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2018-05-09
- 2018-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.44M.
- 2017-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.56M.
- 2017-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.00K.
- 2016-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2018-03-31 | $4.44M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $5.56M 10-Q · filed 2018-05-09 |
| 2017-03-31 | $24.00K 10-Q · filed 2018-05-09 |
| 2016-12-31 | $15.00K 10-Q · filed 2018-05-09 |
| 2015-12-31 | $67.00K 10-K · filed 2018-03-01 |
| 2014-12-31 | $6.00K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |